SCHEMBL7657882

SCHEMBL7657882

CC(=O)NC1CCc2cccc(N)c2C1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 1/20 0.51
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MTNR1A P48039 4/20 0.44
MTNR1B P49286 4/20 0.44
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CRBN Q96SW2 3/20 0.38
CYP2C9 P11712 3/20 0.38
TUBB1 Q9H4B7 3/20 0.38
TSHR P16473 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664409 0.92 LMNA (0.43) LMNAKDM4EPOLBMAPTCA12
SCHEMBL7653374 0.82 KDM4E (0.50) LMNAKDM4EPOLBMAPTCA12
SCHEMBL7654640 0.80 LMNA (0.50) LMNAKDM4EPOLBMAPTCA12
SCHEMBL30841586 0.80 CA12 (0.42) LMNAKDM4EPOLBMAPTCA12
SCHEMBL26155089 0.78 CA12 (0.41) LMNAKDM4EPOLBMAPTCA12
SCHEMBL7659820 0.77 LMNA (0.47) LMNAKDM4EPOLBMAPTCA12
SCHEMBL30721496 0.77 NPC1 (0.67) LMNAKDM4EPOLBMAPTCA12
SCHEMBL697728 0.77 NPC1 (0.67) LMNAKDM4EPOLBMAPTCA12
SCHEMBL7655081 0.76 LMNA (0.62) LMNAKDM4EPOLBMAPTMTNR1A
SCHEMBL7661612 0.76 LMNA (0.46) LMNAKDM4EPOLBMAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407115-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS; SIDE EFFECT REDUCTION, WATER SOLUBILITY DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-06-18 US disclosed
US-5834476-A DERIVATIVE OF CAMPTOTHECIN, ANTITUMOR AGENT, ANTICARCINOGENIC AGENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
US-5770605-A Method for treating leukemia with a hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-06-23 US disclosed
US-5658920-A ANTITUMOR AGENTS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-08-19 US disclosed
US-5637770-A Hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-10 US disclosed
EP-0495432-B1 Hexa-cyclic compound DAIICHI SEIYAKU CO (JP) 1996-05-29 EP disclosed
EP-0495432-A1 Hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1992-07-22 EP disclosed